Royalty Pharma plc
USD54.01
-1.17 (-2.12%)
CEO
Pablo Legorreta
IPO Date
2020-06-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$55.00
Prev. Close
$55.18
Day Low
$53.98
Day High
$55.25
52W Low
$32.85
52W High
$56.07
Market Cap
$23.23B
Volume
2.29M
| 13,684 |
| $52.75 |
| 15 May 2026 | Urist Marshall | EVP, Research & Investments | S-Sale | Disposed | 13,684 | $53.06 |
| 15 May 2026 | Norden Gregory | director | S-Sale | Disposed | 3,045 | $53.00 |
| 8 May 2026 | Legorreta Pablo G. | director, officer: CEO, Chairman of the Board | A-Award | Acquired | 143,821 | $0.00 |
| 8 May 2026 | Coyne Terrance P. | EVP & CFO | A-Award | Acquired | 24,263 | $0.00 |
| 8 May 2026 | Hite Christopher | EVP & Vice Chairman | A-Award | Acquired | 24,263 | $0.00 |
| 8 May 2026 | Urist Marshall | EVP, Research & Investments | A-Award | Acquired | 18,197 | $0.00 |
| 30 Apr 2026 | Coyne Terrance P. | EVP & CFO | S-Sale | Disposed | 32,916 | $49.78 |
| 30 Apr 2026 | Coyne Terrance P. | EVP & CFO | S-Sale | Disposed | 1,875 | $49.78 |